Medibio building credentials to “scale” via appointment of healthcare & telehealth icon to Board of Directors
July 19, 2017 09:00 ET
|
Medibio Limited
SYDNEY, Australia and MINNEAPOLIS, July 19, 2017 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a digital health company that has developed an objective testing...
Persisting Gaps in Cancer Care Negatively Impact Patient Outcomes
July 18, 2017 07:30 ET
|
Cancer Support Community
PHILADELPHIA, July 18, 2017 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC), an international nonprofit organization, today released a research report that found the scarcity of communication...
MYnd Analytics Announces Uplisting to NASDAQ and Pricing of $8.79M Underwritten Offering
July 14, 2017 08:30 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., July 14, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive analytics company which brings objective physical findings to psychiatric treatment in order...
MYnd Analytics Declares Special Dividend of Common Stock Warrants to all holders of Common Stock as of July 13, 2017
July 13, 2017 19:38 ET
|
MYnd Analytics, Inc.
NEW YORK, July 13, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:MYAN), announced that it had established July 13, 2017 as the record date for the determination of stockholders entitled to...
Scientific breakthrough on objective diagnosis of PTSD
June 26, 2017 10:40 ET
|
Medibio Limited
Scientific breakthrough for non-invasive, automatic, objective diagnosis of PTSD leveraging autonomic biomarkersAccuracy of 80% (+/- 1%) for objectively diagnosing subjects with PTSDMedibio has...
Walter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of Depression
June 22, 2017 17:12 ET
|
Brainsway Ltd.
HACKENSACK, N.J., June 22, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, today...
CORRECTING and REPLACING – Brainsway Reports Strong Momentum in Q1 for 2017
June 08, 2017 17:09 ET
|
Brainsway Ltd.
HACKENSACK, N.J., June 08, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline on June 6th by Brainsway Ltd. (TASE:BRIN), please note in the fifth paragraph, the third...
Brainsway Reports Strong Momentum in Q1 for 2017
June 06, 2017 13:20 ET
|
Brainsway Ltd.
HACKENSACK, N.J., June 06, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced...
Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder
May 17, 2017 16:05 ET
|
Neuralstem, Inc.
GERMANTOWN, Md., May 17, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, today announced it has...
Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update
May 10, 2017 16:05 ET
|
Neuralstem, Inc.
GERMANTOWN, Md., May 10, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, reported its financial...